NCT05477823 2026-01-28
Imaging and Genomic Biomarkers to Predict Response in Prostate Cancer
University of Wisconsin, Madison
Phase EARLY_PHASE1 Active not recruiting
Clinical Trials
17 trialsNCT05133440 2026-01-21
A Study of Stereotactic Body Radiation Therapy and Radium (Ra-223) Dichloride in Prostate Cancer That Has Spread to the Bones
Memorial Sloan Kettering Cancer Center
Phase 2 Active not recruiting
NCT05470699 2025-12-17
RefleXion PET/CT Imaging Performance in Patients With Prostate Cancer
City of Hope Medical Center
Phase NA Active not recruiting
NCT07249281 2025-11-25
MR Microstructural Imaging for Prostate Cancer Diagnosis
First Affiliated Hospital of Zhejiang University
Recruiting
NCT06862856 2025-11-13
Flotufolastat F 18 PET in Men With Very Low PSA Recurrence
Massachusetts General Hospital
Recruiting
NCT04186845 2025-09-22
Imaging Study to Investigate Safety and Diagnostic Performance of 18F rhPSMA 7.3 PET Ligand in Suspected Prostate Cancer Recurrence
Blue Earth Diagnostics
Phase 3 Completed
NCT00924027 2025-09-05
A Study of Patients Receiving High-Dose Rate Brachytherapy
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT04053842 2025-03-13
IGPC-5
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Phase 2 Active not recruiting
NCT04186819 2025-02-26
Imaging Study to Investigate the Safety and Diagnostic Performance of rhPSMA 7.3 (18F) in Newly Diagnosed Prostate Cancer.
Blue Earth Diagnostics
Phase 3 Completed
NCT02809690 2023-09-07
18F-FMAU PET/CT in Diagnosing and Characterizing Prostate Cancer
University of Southern California
Phase 1 Terminated
NCT04521894 2023-06-09
The Application Value of 18F-prostate-specific Membrane Antigen PET/CT in Prostate Cancer
First Affiliated Hospital Xi'an Jiaotong University
Unknown
NCT04348682 2021-06-24
Expanded Access Protocol of 68Ga-PSMA-11 for PET Imaging
Jonsson Comprehensive Cancer Center
Approved for marketing
NCT02611882 2020-12-22
PSMA PET
University of California, San Francisco
Phase 2 Completed
NCT01479348 2020-06-02
Imaging Study for FdCyd and THU Cancer Treatment
National Institutes of Health Clinical Center (CC)
Phase EARLY_PHASE1 Terminated
NCT01205646 2019-04-12
PET Scanning to Evaluate Zoledronate Efficacy in Metastatic Prostate Cancer
Barbara Ann Karmanos Cancer Institute
Phase NA Completed
NCT02805608 2018-04-11
uPAR PET/CT and FDG PET/MRI for Preoperative Staging of Bladder Cancer
Rigshospitalet, Denmark
Phase 2 Unknown
NCT02437539 2015-08-24
uPAR-PET
Rigshospitalet, Denmark
Phase 1 Completed